Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Safety of Endoscopy in Heritable Connective Tissue Disorders.

Kilaru SM, Mukamal KJ, Nee JW, Oza SS, Lembo AJ, Wolf JL.

Am J Gastroenterol. 2019 Mar 12. doi: 10.14309/ajg.0000000000000189. [Epub ahead of print]

PMID:
31185005
2.

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Lacy BE, Harris LA, Chang L, Lucak S, Gutman C, Dove LS, Covington PS, Lembo A.

Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841290. doi: 10.1177/1756284819841290. eCollection 2019.

3.

Chronic Diarrhea and Constipation are More Common in Depressed Individuals.

Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, Iturrino J, Lembo A, Nee J.

Clin Gastroenterol Hepatol. 2019 Apr 4. pii: S1542-3565(19)30362-3. doi: 10.1016/j.cgh.2019.03.046. [Epub ahead of print]

PMID:
30954714
4.

Oculofacial alterations in NBAS-SOPH like mutations: Case report.

Nucci F, Lembo A, Farronato M, Farronato G, Nucci P, Serafino M.

Eur J Ophthalmol. 2019 Mar 8:1120672119836335. doi: 10.1177/1120672119836335. [Epub ahead of print]

PMID:
30845840
5.

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.

Nee JW, Johnston JM, Shea EP, Walls CE, Tripp K, Shiff S, Fox SM, Bochenek W, Weissman D, Currie MG, Lembo AJ.

Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):397-406. doi: 10.1080/17474124.2019.1575203. Epub 2019 Feb 18.

PMID:
30791771
6.

Fecal urgency is common in constipated patients and is associated with anxiety.

Singh P, Takazawa E, Rangan V, Ballou S, Katon J, McMahon C, Lee HN, Iturrino J, Nee J, Lembo A.

Neurogastroenterol Motil. 2019 Apr;31(4):e13545. doi: 10.1111/nmo.13545. Epub 2019 Feb 3.

PMID:
30714267
7.

Prevalence of Functional GI Diseases and Pelvic Floor Symptoms in Marfan Syndrome and Ehlers-Danlos Syndrome: A National Cohort Study.

Nee J, Kilaru S, Kelley J, Oza SS, Hirsch W, Ballou S, Lembo A, Wolf J.

J Clin Gastroenterol. 2019 Jan 21. doi: 10.1097/MCG.0000000000001173. [Epub ahead of print]

PMID:
30672816
8.

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia.

Singh P, Seo Y, Ballou S, Ludwig A, Hirsch W, Rangan V, Iturrino J, Lembo A, Nee JW.

J Neurogastroenterol Motil. 2019 Jan 31;25(1):129-136. doi: 10.5056/jnm17139.

9.

Clinical and manometric characteristics of women with paradoxical puborectalis syndrome.

Rangan V, Zakari M, Hirsch W, Ballou S, Singh P, Sommers T, Iturrino J, Nee J, Staller K, Lembo A.

United European Gastroenterol J. 2018 Dec;6(10):1578-1585. doi: 10.1177/2050640618798227. Epub 2018 Sep 3.

10.

Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department.

Sommers T, Petersen T, Singh P, Rangan V, Hirsch W, Katon J, Ballou S, Cheng V, Friedlander D, Nee J, Lembo A, Iturrino J.

Dig Dis Sci. 2019 May;64(5):1320-1327. doi: 10.1007/s10620-018-5394-8. Epub 2018 Dec 8.

PMID:
30535766
11.

Choroidal biomarkers.

Pichi F, Aggarwal K, Neri P, Salvetti P, Lembo A, Nucci P, Gemmy Cheung CM, Gupta V.

Indian J Ophthalmol. 2018 Dec;66(12):1716-1726. doi: 10.4103/ijo.IJO_893_18. Review.

12.

Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States.

Sommers T, Mitsuhashi S, Singh P, Hirsch W, Katon J, Ballou S, Rangan V, Cheng V, Friedlander D, Iturrino J, Lembo A, Nee J.

Am J Gastroenterol. 2019 Jan;114(1):135-142. doi: 10.1038/s41395-018-0418-8.

PMID:
30410038
13.

Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Vagge A, Ferro Desideri L, Nucci P, Serafino M, Giannaccare G, Lembo A, Traverso CE.

Diseases. 2018 Oct 22;6(4). pii: E96. doi: 10.3390/diseases6040096. Review.

14.

The Prevalence of Gastroesophageal Reflux in Patients With Excessive Central Airway Collapse.

Majid A, Kheir F, Alape D, Kent M, Lembo A, Rangan VV, Carreiro M, Gangadharan SP.

Chest. 2019 Mar;155(3):540-545. doi: 10.1016/j.chest.2018.09.021. Epub 2018 Oct 9.

PMID:
30312588
15.

Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy.

Pichi F, Fragiotta S, Freund KB, Au A, Lembo A, Nucci P, Sebastiani S, Gutierrez Hernandez JC, Interlandi E, Pellegrini F, Dolz-Marco R, Gallego-Pinazo R, Orellana-Rios J, Adatia FA, Munro M, Abboud EB, Ghazi N, Cunha Souza E, Amer R, Neri P, Sarraf D.

Br J Ophthalmol. 2018 Sep 26. pii: bjophthalmol-2018-312774. doi: 10.1136/bjophthalmol-2018-312774. [Epub ahead of print]

PMID:
30257961
16.

Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic.

Ballou S, Alhassan E, Hon E, Lembo C, Rangan V, Singh P, Hirsch W, Sommers T, Iturrino J, Nee J, Lembo A.

Dig Dis Sci. 2018 Nov;63(11):2983-2991. doi: 10.1007/s10620-018-5237-7. Epub 2018 Aug 9.

PMID:
30094624
17.

Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome.

Huang CY, Daniels R, Lembo A, Hartog C, O'Brien J, Heymann T, Reinhart K, Nguyen HB; Sepsis Survivors Engagement Project (SSEP).

Int J Qual Health Care. 2019 Apr 1;31(3):191-198. doi: 10.1093/intqhc/mzy137.

PMID:
29924325
18.

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Fodor AA, Pimentel M, Chey WD, Lembo A, Golden PL, Israel RJ, Carroll IM.

Gut Microbes. 2019;10(1):22-33. doi: 10.1080/19490976.2018.1460013. Epub 2018 Jul 18.

19.

Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract.

Nee J, Rangan V, Lembo A.

Neurogastroenterol Motil. 2018 May;30(5):e13367. doi: 10.1111/nmo.13367. Review.

PMID:
29700963
20.

Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.

Ballou S, Beath A, Kaptchuk TJ, Hirsch W, Sommers T, Nee J, Iturrino J, Rangan V, Singh P, Jones M, Lembo A.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1738-1744.e1. doi: 10.1016/j.cgh.2018.04.009. Epub 2018 Apr 12.

PMID:
29654913
21.

Early metabolic response to acute myocardial ischaemia in patients undergoing elective coronary angioplasty.

Di Marino S, Viceconte N, Lembo A, Summa V, Tanzilli G, Raparelli V, Truscelli G, Mangieri E, Gaudio C, Cicero DO.

Open Heart. 2018 Mar 10;5(1):e000709. doi: 10.1136/openhrt-2017-000709. eCollection 2018.

22.

Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States.

Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V, Iturrino-Moreda J, Friedlander D, Nee J, Lembo A.

Am J Gastroenterol. 2018 Apr;113(4):593-600. doi: 10.1038/ajg.2018.24. Epub 2018 Mar 6.

PMID:
29610515
23.

Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey.

Rangan V, Mitsuhashi S, Singh P, Ballou S, Hirsch W, Sommers T, Nee J, Iturrino J, Lembo A.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1450-1458.e2. doi: 10.1016/j.cgh.2018.02.020. Epub 2018 Feb 21.

PMID:
29474972
24.

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Ballou S, Hirsch W, Singh P, Rangan V, Nee J, Iturrino J, Sommers T, Zubiago J, Sengupta N, Bollom A, Jones M, Moss AC, Flier SN, Cheifetz AS, Lembo A.

Aliment Pharmacol Ther. 2018 Apr;47(7):913-921. doi: 10.1111/apt.14551. Epub 2018 Feb 7.

25.

Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.

Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1569-1584.e2. doi: 10.1016/j.cgh.2018.01.021. Epub 2018 Jan 31. Review.

PMID:
29374616
26.

Accommodative esotropia: the state of the art.

Lembo A, Serafino M, Strologo MD, Saunders RA, Trivedi RH, Villani E, Nucci P.

Int Ophthalmol. 2019 Feb;39(2):497-505. doi: 10.1007/s10792-018-0821-6. Epub 2018 Jan 13. Review.

PMID:
29332227
27.

Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013.

Hirsch W, Nee J, Ballou S, Petersen T, Friedlander D, Lee HN, Cheng V, Lembo A.

J Clin Gastroenterol. 2019 Feb;53(2):109-113. doi: 10.1097/MCG.0000000000000972.

PMID:
29256990
28.

Chronic constipation.

Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simrén M, Lembo A, Young-Fadok TM, Chang L.

Nat Rev Dis Primers. 2017 Dec 14;3:17095. doi: 10.1038/nrdp.2017.95. Review.

PMID:
29239347
29.

Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.

Bollom A, Austrie J, Hirsch W, Nee J, Friedlander D, Iturrino J, Ballou S, Lembo A.

J Clin Gastroenterol. 2018 Oct;52(9):778-783. doi: 10.1097/MCG.0000000000000944.

PMID:
29095419
30.

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Schoenfeld P, Lacy BE, Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, OʼDea CR, Omniewski ND, Hall ML.

Am J Gastroenterol. 2018 Jan;113(1):105-114. doi: 10.1038/ajg.2017.230. Epub 2017 Aug 22.

31.

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.

Cash BD, Pimentel M, Rao SSC, Weinstock L, Chang L, Heimanson Z, Lembo A.

Therap Adv Gastroenterol. 2017 Sep;10(9):689-699. doi: 10.1177/1756283X17726087. Epub 2017 Sep 11.

32.

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.

Delgado-Herrera L, Lasch K, Zeiher B, Lembo AJ, Drossman DA, Banderas B, Rosa K, Lademacher C, Arbuckle R.

Therap Adv Gastroenterol. 2017 Sep;10(9):673-687. doi: 10.1177/1756283X17726018. Epub 2017 Aug 24.

33.

Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.

Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P.

Dig Dis Sci. 2017 Oct;62(10):2945. doi: 10.1007/s10620-017-4729-1. No abstract available.

PMID:
28884456
34.

Characterizing Normal Bowel Frequency and Consistency in a Representative Sample of Adults in the United States (NHANES).

Mitsuhashi S, Ballou S, Jiang ZG, Hirsch W, Nee J, Iturrino J, Cheng V, Lembo A.

Am J Gastroenterol. 2018 Jan;113(1):115-123. doi: 10.1038/ajg.2017.213. Epub 2017 Aug 1.

PMID:
28762379
35.

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.

Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P.

Dig Dis Sci. 2017 Sep;62(9):2455-2463. doi: 10.1007/s10620-017-4598-7. Epub 2017 Jun 6. Erratum in: Dig Dis Sci. 2017 Sep 7;:.

36.

Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.

Lacy BE, Chey WD, Cash BD, Lembo AJ, Dove LS, Covington PS.

Am J Gastroenterol. 2017 Jul;112(7):1210. doi: 10.1038/ajg.2017.152. Epub 2017 May 30.

PMID:
28555632
37.

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.

Ballou S, Kaptchuk TJ, Hirsch W, Nee J, Iturrino J, Hall KT, Kelley JM, Cheng V, Kirsch I, Jacobson E, Conboy L, Lembo A, Davis RB.

Trials. 2017 May 25;18(1):234. doi: 10.1186/s13063-017-1964-x.

38.

Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.

Camilleri M, Lembo A, Katzka DA.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1338-1349. doi: 10.1016/j.cgh.2017.05.014. Epub 2017 May 19. Review.

39.

Pseudoachalasia Secondary to Thoracic Aortic Aneurysm.

Beqari J, Lembo A, Critchlow J, Hamden A, Kent MS.

Ann Thorac Surg. 2017 Jun;103(6):e517-e518. doi: 10.1016/j.athoracsur.2016.11.084.

PMID:
28528055
40.

Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation.

Brühlmann D, Muhr A, Parker R, Vuillemin T, Bucsella B, Kalman F, Torre S, La Neve F, Lembo A, Haas T, Sauer M, Souquet J, Broly H, Hemberger J, Jordan M.

J Biotechnol. 2017 Jun 20;252:32-42. doi: 10.1016/j.jbiotec.2017.04.026. Epub 2017 Apr 29.

PMID:
28465212
41.

The role of dietary approach in irritable bowel syndrome.

Portincasa P, Lembo A, De Bari O, Di Palo DM, Maggio A, Cataldo I, Calamita G.

Curr Med Chem. 2017 Apr 27. doi: 10.2174/0929867324666170428102451. [Epub ahead of print]

PMID:
28462704
42.

Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.

Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M.

Dig Dis Sci. 2017 Jun;62(6):1480-1485. doi: 10.1007/s10620-017-4585-z. Epub 2017 Apr 27.

PMID:
28451914
43.

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.

Lacy BE, Chey WD, Cash BD, Lembo AJ, Dove LS, Covington PS.

Am J Gastroenterol. 2017 Jun;112(6):924-932. doi: 10.1038/ajg.2017.72. Epub 2017 Apr 18. Erratum in: Am J Gastroenterol. 2017 Jul;112(7):1210.

44.

Reply.

Lembo AJ.

Gastroenterology. 2017 May;152(6):1630-1631. doi: 10.1053/j.gastro.2017.03.042. Epub 2017 Apr 3. No abstract available.

PMID:
28384458
45.

Editorial: latent class analysis to improve confidence in the diagnosis of IBS.

Ballou S, Lembo A.

Aliment Pharmacol Ther. 2017 May;45(9):1267-1268. doi: 10.1111/apt.14002. No abstract available.

46.

Emergency Department Burden of Diverticulitis in the USA, 2006-2013.

Bollom A, Austrie J, Hirsch W, Nee J, Friedlander D, Ellingson K, Cheng V, Lembo A.

Dig Dis Sci. 2017 Oct;62(10):2694-2703. doi: 10.1007/s10620-017-4525-y. Epub 2017 Mar 22.

47.

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.

Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M.

Am J Gastroenterol. 2017 May;112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21.

48.

Irritable Bowel Syndrome: An Infectious Disease?

Quigley EMM, Lembo AJ.

Gastroenterology. 2017 Apr;152(5):936-938. doi: 10.1053/j.gastro.2017.02.028. Epub 2017 Mar 1. No abstract available.

PMID:
28259791
49.

Editorial: ONO-2952 in irritable bowel syndrome with diarrhoea.

Nee J, Lembo A.

Aliment Pharmacol Ther. 2017 Apr;45(7):1004-1005. doi: 10.1111/apt.13920. No abstract available.

50.

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.

Chey WD, Lembo AJ, Rosenbaum DP.

Am J Gastroenterol. 2017 May;112(5):763-774. doi: 10.1038/ajg.2017.41. Epub 2017 Feb 28.

Supplemental Content

Support Center